The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Open accessThe DOI matches its Crossref record; 119 of the 140 references it cites were found in a registry or an index; 9 of the 77 sources its claims cite were checked for support.
Abstract
OBJECTIVE: The objective of the study was to develop clinical practice guidelines for the diagnosis of Cushing's syndrome. PARTICIPANTS: The Task Force included a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, five additional experts, a methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage the Task Force incorporated needed changes in response to written comments. CONCLUSIONS: After excluding exogenous glucocorticoid use, we recommend testing for Cushing's syndrome in patients with multiple and progressive features compatible with the syndrome, particularly those with a high discriminatory value, and patients with adrenal incidentaloma. We recommend initial use of one test with high diagnostic accuracy (urine cortisol, late night salivary cortisol, 1 mg overnight or 2 mg 48-h dexamethasone suppression test). We recommend that patients with an abnormal result see an endocrinologist and undergo a second test, either one of the above or, in some cases, a serum midnight cortisol or dexamethasone-CRH test. Patients with concordant abnormal results should undergo testing for the cause of Cushing's syndrome. Patients with concordant normal results should not undergo further evaluation. We recommend additional testing in patients with discordant results, normal responses suspected of cyclic hypercortisolism, or initially normal responses who accumulate additional features over time.
Overview
CoChat Summary
TL;DR
This Endocrine Society guideline recommends case detection for Cushing's syndrome only in selected high-risk groups, initial testing with one of four high-accuracy tests, and confirmatory second testing before cause-directed evaluation. It emphasizes excluding exogenous glucocorticoids first and notes that most recommendations rest on very low- to low-quality evidence.
Key findings
- Exclude exogenous glucocorticoid exposure before biochemical testing (1QQQQ); test patients with multiple and progressive features, unusual features for age, children with decreasing height percentile and increasing weight, or adrenal incidentaloma compatible with adenoma, and recommend against widespread testing in other groups.
- Initial testing should use one of: urine free cortisol (at least two measurements), late-night salivary cortisol (two measurements), 1-mg overnight dexamethasone suppression test, or 48-h 2 mg/d dexamethasone suppression test; recommend against random serum cortisol/plasma ACTH, urinary 17-ketosteroids, insulin tolerance test, loperamide test, and cause-directed tests for initial diagnosis.
- Reported test performance includes late-night salivary cortisol sensitivity 92–100% and specificity 93–100%; pediatric UFC sensitivity about 89%; 1-mg DST at a 1.8 µg/dL cutoff sensitivity >95% with specificity 80%, rising to >95% specificity at a 5 µg/dL threshold; LDDST sensitivity 96% and specificity 70%; dexamethasone-CRH sensitivity 98% and specificity 60%.
- Special-population recommendations: use UFC and avoid dexamethasone testing in pregnancy; avoid dexamethasone testing with enzyme-inducing antiepileptics; suggest 1-mg overnight DST rather than UFC in severe renal failure; suggest UFC or midnight salivary cortisol rather than DSTs in suspected cyclic Cushing's; suggest 1-mg DST or late-night cortisol rather than UFC in adrenal incidentaloma.
Methods
- A six-member Task Force appointed by The Endocrine Society's Clinical Guidelines Subcommittee, including a chair, five additional experts, a methodologist, and a medical writer, received no corporate funding or remuneration; consensus was guided by systematic reviews and discussions and approved sequentially by Society bodies and members.
- Recommendations used the GRADE approach: strong recommendations phrased “we recommend” with number 1, weak recommendations “we suggest” with number 2; evidence quality ranged from QEEE (very low) to QQQQ (high), informed by best available research evidence and systematic reviews/meta-analyses of test accuracy.
- The guideline presents evidence, values, and remarks linked to each recommendation; technical remarks often reflect the panel's unsystematic observations applied to a typical patient.
Limitations
- Stated: the majority of recommendations are based on very low- to low-quality evidence, with limited data linking diagnostic strategies to patient-important outcomes and no higher-quality direct evidence available.
- Stated: published data often come from larger tertiary referral centers and may be biased toward more diagnostically challenging cases, higher pretest probability, and greater disease severity, potentially giving an overly sanguine view of test performance in unselected populations.
- Evident from the text: this is a consensus guideline rather than a primary study, and some technical recommendations rest on unsystematic panel observations; data on treating mild/subclinical Cushing's syndrome and adrenal incidentaloma are described as limited and conflicting.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 37 Not checked · 33 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Another study of 86 consecutive obese subjects referred to an endocrine clinic with diabetes mellitus, hypertension, and/or the polycystic ovary syndrome found a 5.8% incidence of Cushing's syndrome (35).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.3 Evidence
What the sources say
- Partly supportedcites [35] 35. Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L 2002 Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese. Obes Res 10:1217-1221 sourceExperimental — accuracy not yet measured
The Patients section describes 86 obese patients referred to an endocrine clinic, and the Results report five Cushing’s syndrome diagnoses—5/86, or approximately 5.8%, though the paper prints 5.7%. The copy does not say the patients were consecutive. It also reports that 51 had obesity alone, so diabetes, hypertension, and polycystic ovary disease do not describe the whole group. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The salivary glands express 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which converts the biologically active cortisol to inactive cortisone (75).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.2 Remarks for late-night salivary cortisol
What the sources say
- Supportedcites [75] 75. Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fuku- shima K, Krozowski ZS 1996 Localization of 11-hydroxysteroid dehydro- genase type II in human epithelial tissues. J Clin Endocrinol Metab 81:3244 - 3248 source
The paper reports 11β-HSD2 in the ducts of human parotid and submandibular salivary glands (Abstract; Discussion, p. 3247). It describes the enzyme as inactivating glucocorticoids and discusses salivary cortisol-to-cortisone ratios (Introduction; Discussion, p. 3247), supporting the stated function. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Overall, the evidence in adults suggests that the accuracy of this test is similar to that of UFC (2).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.2 Evidence for late-night salivary cortisol
What the sources say
- Supportedcites [2] 2. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562 source
Table 3 (Conclusions; page unavailable) reports broadly similar pooled diagnostic likelihood ratios for midnight salivary cortisol and UFC. The Summary of findings notes that evidence for salivary cortisol is more limited, consistent with the citing sentence’s cautious wording. (LLM, conf=0.88)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“When the assay upper limit of normal is used as a criterion, the overall evidence supports the diagnostic accuracy of UFC in adults suspected of having Cushing's syndrome (2,51).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4.1 Evidence for use of UFC
What the sources say
- Partly supportedcites [2] 2. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562 sourceExperimental — accuracy not yet measured
The Summary of findings says UFC has substantial evidence supporting its use to detect Cushing’s syndrome, and the pooled results table reports diagnostic accuracy across 14 UFC studies. The Subgroup analyses section identifies an assay-upper-limit cutoff, but the reported UFC estimate is pooled across studies rather than shown specifically for that cutoff. The Conclusions also limit the apparent accuracy to referral practices enriched with patients with Cushing’s syndrome; performance in usual clinical practice remains unclear. Page numbers were not available in our copy. (LLM, conf=0.83)
- Supportedcites [51] 51. Pecori Giraldi F, Ambrogio AG, De Martin M, Fatti LM, Scacchi M, Cav- agnini F 2007 Specificity of first-line tests for the diagnosis of Cushing's syndrome: assessment in a large series. J Clin Endocrinol Metab 92:4123- 4129 source
The UFC results (p. 2) report 91.2% specificity in Cushing’s syndrome suspects when values above the assay’s reference range were considered abnormal. The Discussion (p. 5) identifies that threshold as the assay’s upper limit of normal and describes UFC as having superior diagnostic performance. The study assessed specificity, rather than diagnostic accuracy across all measures. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The four recommended tests have acceptable diagnostic accuracy when the suggested cutoff points are used (2,30).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.4 Evidence
What the sources say
- Partly supportedcites [2] 2. Elamin MB, Murad MH, Mullan R, Erickson D, Harris K, Nadeem S, Ennis R, Erwin PJ, Montori VM 2008 Accuracy of diagnostic tests for Cushing syndrome: a systematic review and meta-analyses. J Clin Endocrinol Metab 93:1553-1562 sourceExperimental — accuracy not yet measured
The Conclusions state that commonly used tests appear highly accurate in referral practices with samples enriched for Cushing’s syndrome, but that their performance in usual clinical practice is unclear. The Data extraction section says the review used cutoffs chosen by the primary studies, selecting those with the best performance when several were available; it does not establish accuracy specifically at the suggested cutoff points. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [30] 30. Batista DL, Riar J, Keil M, Stratakis CA 2007 Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120: e575-e586 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
48 more claims · 3 with their cited sources checked
Create a free account to see all 82 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early diagnosis of secondary hypertension and the institution of appropriate targeted treatment have the potential to cure hypertension in some patients or improve BP control/reduce the number of prescribed antihypertensive medications in others.”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, accurate serum cortisol measurement is essential for the correct diagnosis and management of adrenal pathologies.”
From Serum cortisol: an up-to-date assessment of routine assay performance (2016) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the reliability of almost all markers of HPA axis activity, particularly ACTH and 24-h urinary free cortisol (UFC), is low (3,14,23)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, UFC should not be considered an adequate screening test for SH and should be used in combination with other tests or in specific populations (1,14).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some authors have proposed higher (3 or 8 mg) dexamethasone doses (40,46,54,56), which however did not show a better performance (14,23,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [14]
Experimental — accuracy not yet measured
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.2 Evidence
“biochemical hypercortisolism is present in a large fraction (up to 10%).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > 3.2 Evidence
“Libe et al. (32) reported 18%; Terzolo et al. (21) quoted 5-20%, depending on referral bias and diagnostic tests and criteria.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > Subsequent evaluation
“3.9.1 We suggest the additional use of the dexamethasone-CRH test or the midnight serum cortisol test in specific situations (Fig. 1, 1QEEE).”
§ The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline > METHOD OF DEVELOPMENT OF EVIDENCE-BASED RECOMMENDATIONS
“strong recommendations use the phrase "we recommend" and the number 1, and weak recommendations use the phrase "we suggest" and the number 2.”
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“with expertise in development and implementation of evidencebased guidelines (1).”
BackgroundCushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851 · cited 1×
“6 yr, and in 1952 a 5-yr survival of just 50%, with most deaths caused by vascular (myocardial infarction, cerebrovascular accident) or infectious complications (11, 12).”
BackgroundThe Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833
Self-citationGold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Self-citationThe natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763 · cited 1×
“6 yr, and in 1952 a 5-yr survival of just 50%, with most deaths caused by vascular (myocardial infarction, cerebrovascular accident) or infectious complications (11, 12).”
BackgroundTESTS OF PITUITARY-ADRENAL SUPPRESSIBILITY IN THE DIAGNOSIS OF CUSHING'S SYNDROME*
LIDDLE, G. W. (1960) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-20-12-1539 · Cited by 735
Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease
Wei, L., MacDonald, T. M., & Walker, B. R. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00007 · Cited by 730 · cited 1×
“These data are consistent with the increased cardiovascular mortality and morbidity reported in patients with iatrogenic Cushing’s syndrome secondary to the chronic use of synthetic corticosteroids (15).”
ResultMeasurements of Serum Free Cortisol in Critically Ill Patients
Hamrahian, A. H., Oseni, T. S., & Arafah, B. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa020266 · Cited by 726 · cited 1×
“are associated with decreased serum cortisol values (39, 46).”
BackgroundMorbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622 · cited 2×
“0-fold, compared with the general population (4, 5).”
BackgroundIncidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619 · cited 6×
“Because some patients with Cushing’s disease demonstrate suppressibility to dexamethasone, use of this diagnostic criterion J Clin Endocrinol Metab, May 2008, 93(5):1526–1540 jcem.”
BackgroundInfluential
Cited by
Items 2,101–2,200 of 2,716
Aulinas, A. (2015) · TDX (Tesis Doctorals en Xarxa)
ADRENAL INCIDENTALOMAS: DIAGNOSIS AND MANAGEMENT
Grineva, E. N., Belousova, L., & Basek, I. V. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-6-532-537 · Cited by 1
Faßnacht, M., & Kiess, W. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50267-3
Tritos, N. A., & Biller, B. M. K. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_6
“The possibility of a pseudo-Cushing’s state should also be considered early during the course of investigation for suspected cyclic CD, and the presence of conditions known to be associated with hypercortisolemia, including major depression, anorexia, strenuous exercise, and alcohol excess among others, should be soug…”
BackgroundSelf-citationRomanholi, D. J. P. C. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2010.tde-21092010-095750
Medical Assessment and Preparation of Patients Undergoing Bariatric Surgery
Bun, W., & Taheri, S. (2012) · InTech eBooks · doi:10.5772/32798
“In patients with morbid obesity, mild hypercortisolaemia could be found with increased urinary free cortisol level (Nieman, Biller et al. 2008).”
BackgroundThe Development of a Non-invasive Short Synacthen Test
Elder, C. J. (2015) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Pituitary Corticotroph Microadenomas VersusMacroadenomas Causing Cushing’s Disease
Aydın, K., Dağdelen, S., Özgen, B., Oruçkaptan, H., Söylemezoğlu, F., & Erbas, T. A. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Management of Pituitary Adenomas
D’Haens, J. (2009) · Springer eBooks · doi:10.1007/978-3-211-84820-3_44
“In the event of a negative MRI, bilateral inferior petrosal sinus sampling (IPSS) is advocated to confi rm the central origin of hypercortisolism [9] and to determine the lateralization of the lesion in the pituitary gland.”
BackgroundCarşote, M., Valea, A., Dumitrascu, A. S., Terzea, D. C., Paun, S. C., Păun, D. L., & Poiană, C. (2015) · International Journal of Diagnostic Imaging · doi:10.5430/ijdi.v2n2p90
Reversibles metabolisches Syndrom hormoneller Ursache
Bala, M., Guralnik, V., Schuierer, G. R., Ullrich, W., Schölmerich, J., & Schäffler, A. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1114-z
Alencar, G. A. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2013.tde-03122013-091817 · Cited by 2
DIAGNÓSTICO Y TRATAMIENTO DE TUMORES NEUROENDOCRINOS PRODUCTORES DE ACTH.
Ovalles, M. A., Vera, L., & Olivieri, M. B. (2014) · Actualidad Contable FACES · Cited by 1
Indicaciones y secuencia de empleo de las pruebas funcionales hipofisarias. Criterios de valoración
Andújar, P., Fernández-Rodríguez, E., Bernabéu, I., & Casanueva, F. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70383-9
Síndrome de Cushing durante el embarazo: manifestaciones cutáneas secundarias a un tumor suprarrenal
Molgó, M., David Mayerson, B., Pedro Jaramillo, Z., Julio Parra, C., & Sergio González, B. (2013) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262013000400013
“Dentro de ellas, la hipertensión arterial y las alteraciones en el metabolismo de los hidratos de carbono ocurren hasta en un 80% y 25%, respectivamente (1-7).”
BackgroundInfluentialMartin, M. D., Giraldi, F. P., & Cavagnini, F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_6
Petrova, D. V., Dzeranova, L., Grigoriev, A., Ivashchenko, O. V., Lapshina, A., & Vorontsov, A. (2014) · Obesity and metabolism · doi:10.14341/omet2014457-61
Adrenocorticotrophin-dependent hypercortisolism: Imaging versus laboratory diagnosis
Tančić‐Gajić, M., Vujović, S., Ivović, M., Stojanovic, M. M., Marina, L., Barać, M., & Micić, D. (2012) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1208500t
Subclinical hypercorticism in patients with metabolic syndrome
Mansour, M., Salam, R., & El-Mogy, F. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1717-5
“The working hypothesis is that even minimal cortisol excess, typically observed in cases of subclinical CS, may contribute to the development of an insulin resistant state leading to metabolic syndrome and may also affect bone health leading to osteoporosis and enhanced susceptibility to fractures (Terzolo et al. 2011…”
BackgroundReproductive function in men presenting with Cushing's disease
Rozhivanov, R. V., Курбатов, Д. Г., & Рожинская, Л. Я. (2010) · Problems of Endocrinology · doi:10.14341/probl201056423-26
Feelders, R. A. (2015) · Bijblijven · doi:10.1007/s12414-015-0031-3
“onderzoek een bron van ectopische ACTH-productie gezocht moeten worden [8].”
BackgroundInfluentialLimitations of dexamethasone suppression tests for Cushing's disease: a reminder!
Bejinariu, E., Soo, S.-C., & Banerjee, R. (2014) · Endocrine Abstracts · doi:10.1530/endoabs.34.p32
Manejo de la enfermedad de Cushing persistente tras cirugía
Rodríguez, J. S. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-538-7.00010-1
Subfertilidade: diagnóstico tardio de síndrome de Cushing
Gonçalves, A. P., Baptista, F., Nobre, E. L., et al. (2014) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2014.09.004
Ectopic ACTH syndrome as a presenting symptom of bronchogenic carcinoma
Adam, S., Kato, R., Rose, S., Bharaj, H., & Basu, A. (2013) · Endocrine Abstracts · doi:10.1530/endoabs.31.p120
Obesidade e hipercortisolismo: armadilhas no diagnóstico
Tavares, A. B. W., Júnior, V. D. S., & Tabet, A. L. O. (2014) · Revista Hospital Universitário Pedro Ernesto · doi:10.12957/rhupe.2014.9804 · Cited by 1
Hipercortisolismo de origen suprarrenal: síndrome de Cushing
Blasco, F. Á., Buesa, M. A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70398-0
Oram, R. A., McDonald, T. J., & Vaidya, B. (2014) · Praxis · doi:10.1024/1661-8157/a001603
16-Year-Old Boy With New-Onset Hypertension and Weight Gain
Hafdahl, L. T., Patel, S. M., & Young, W. F. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.02.012
Liangos, O. (2014) · Interventional Cardiology · doi:10.2217/ica.14.57
Adrenal Incidentalomas with Supraphysiologic Response to ACTH Stimulus: A Case Report
Antonopoulou, M., & Perelstein, A. (2012) · Case Reports in Endocrinology · doi:10.1155/2012/503290
Cicognani, C., Vezzadini, C., Battaglia, S., et al. (2010) · Italian Journal of Medicine · doi:10.1016/j.itjm.2010.01.004
“[9] Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al.”
BackgroundOptimal management of Cushing syndrome
Edgar Gerardo Durán Durán-Pérez Edgar, G., Loza, O. T. M., Tobón, G. C., & Segovia-Palomo, A. (2012) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s25345
“For diagnosis it is worth consulting clinical guides.(11)”
Síndrome de Cushing secundario al uso de esteroides
González, L. S. P., & Rufín, M. G. (2011) · Revista panorama/Panorama. Cuba y salud
Adrenal disease: The GP’s role
Mears, R., & Roberts, A. W. (2015) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738014564901
Easy Bruising in a Patient with Secondary Amenorrhea
Roberts, T. K., & Fantz, C. R. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.207746
RESULTADOS A LARGO PLAZO DE LA RADIOCIRUGÍA EN ADENOMAS HIPOFISARIOS
Martos, Y. S. (2013) · Institutional Repository of the University of Granada (University of Granada) · Cited by 1
5 Dexamethason-remmingstest, 1 mg
van Bergeijk, L., de Bruin, W. I., Doelman, C. J. A., et al. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7711-4_5
Ticse, R. (2012) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272012000100008 · Cited by 1
van Bergeijk, L., de Bruin, W. I., Doelman, C. J. A., et al. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7711-4_6
Trauma - logistics and stress response
Brorsson, C. (2014) · DiVA at Umeå University (Umeå University)
Die Diagnose des Cushing-Syndroms
Stepan, & Einleitung, Ñ. (2009) · Journal für Kardiologie (Krause & Pachernegg GmbH)
¿Deberían modificarse los protocolos diagnóstico-terapéuticos de los incidentalomas suprarrenales?
Mateo-Gavira, I., Vílchez-López, F. J., Larrán-Escandón, L., Ojeda-Schuldt, M. B., Tinoco, C. L., & Aguilar‐Diosdado, M. (2014) · Cirugía Española · doi:10.1016/j.ciresp.2013.09.016 · Cited by 1
Papel da via lkaros-FGFR4 na evolução pós-cirúrgica dos pacientes com doença de Cushing
Brito, L. P. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2010.tde-25052010-172357
Two pregnancies during a nine year period of amenorrhea – a rare presentation of Cushing’s disease
Rajaratnam, H., Dharshini, K., Somasundaram, N. P., et al. (2013) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v3i1.5498
“These results indicate ACTH dependent Cushing’s syndrome or rarely Cushing’s disease which presents with non suppression with high dose dexamethasone in 10% of cases (1).”
Cushing's Syndrome Accompanied with Adrenal and Pancreatic Mass: A Case Report
Amouzegar, A., Ghanei, A., & Azizi, F. (2008) · Intern J Endocrinol Metab
Clues to ovarian tumors: new concepts of symptoms, signs, syndromes, and paraneoplastic syndromes
Altchek, A., & Fishman, D. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003254.022
Beato-Víbora, P. I., Ortega, P. R., & López, M. (2009) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.06.004
Hipertensión de causa adrenal y embarazo
Herrera, O. F. T. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Detección precoz de trastornos endocrinológicos
Trincado, M. P., & Letelier, B. (2010) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(10)70594-0 · Cited by 3
Le syndrome de Cushing infraclinique en cardiologie
Amar, J. (2010) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(10)70144-9
Diabetes and Endocrinology Symposium: thinner, fitter, faster
McManus, F. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/147827152012420401001
Aus der Universitätsklinik für Neurochirurgie Tübingen
Direktor, Ä., & Tatagiba, M. S. (2012)
Cirugía adrenal en un hospital de tercer nivel
Santacruz, M. I. S., Gómez, J. A. J., Ruezga, K. L. L., González, L. R. R., Martín, R. A., Cervantes, L. F. C., & Valles, S. G. A. (2013)
Cushing's disease -- assessing the efficacy of transsphenoidal surgery.
Witek, P., Zieliński, G., Maksymowicz, M., & Kamiński, G. K. E. I. T. I. (2012) · PubMed · Cited by 8
(2011) · Elsevier eBooks · doi:10.1016/b978-0-323-05570-3.00028-x
Niemczyk, L., & Romejko, K. (2012)
Impact of acromegaly and the Cushing's syndrome, a prospect experience
Llanes, L. L., Machado, A. A., Redondo, B. L. F., & Rodríguez, J. H. (2011) · Revista cubana de endocrinología
Silent ACTHoma: A subclinical presentation ofCushing’s disease in a 79 year old male
Malviya, M., Kumar, N., & Ahmad, N. (2013) · International journal of collaborative research on internal medicine & public health
Desta, D., Eck, L. M., & Lowry, B. (2011) · Kansas Journal of Medicine · doi:10.17161/kjm.v4i3.11370
Kaltsas, G., & Chrousos, G. P. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_5
Diagnosi e terapia della malattia di Cushing in età pediatrica
Vottero, A., & Loche, S. (2011) · L Endocrinologo · doi:10.1007/bf03344806
Murray, R. D. (2015) · Springer eBooks · doi:10.1007/978-1-4471-2789-5_6
“The diurnal rhythm of cortisol is affected by shift work, depression, and critical illness making midnight serum cortisol and salivary free cortisol measures unreliable in these circumstances [ 7 ].”
BackgroundInfluentialMÁSTER EN INVESTIGACIÓN BIOMÉDICA TRASLACIONAL
Castano, J. P., Luque, R. M., & Gahete, M. D. (2013)
Endocrine Disorders Associated with Obesity
Park, H.-K., & Ahima, R. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_42-1
Exogenous Cushing?s Syndrome:The Cause Finding Difficulties
Baloescu, M. C. R. (2015) · Primary Health Care Open Access · doi:10.4172/2167-1079.1000i101
“Key words: Cushing’s syndrome; Striae; Obesity Cushing’s syndrome (CS) is more frequent associated with exogenous sources of glucocorticoids which are usually revealed by patients’ anamnesis or medical records [1].”
BackgroundSpecial Aspects of Cushing’s Syndrome: Childhood
Savage, M. O., Afshar, F., Plowman, N. P., Dias, R. P., Grossman, A. B., & Storr, H. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-449-4_22
Self-citationSurgical Management of Adrenocorticotropic Hormone-Secreting Pituitary Adenomas
Kulubya, E. S., Donoho, D. A., Carmichael, J. D., & Zada, G. (2016) · International Journal of Endocrine Oncology · doi:10.2217/ije.15.26
Atividade do eixo hipotálamo-hipófise-adrenal em portadores de diabetes mellitus tipo 2
de Melo, A. P. M. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.12.d.19391
TRABAJOS ESPECIALES MANEJO DE PACIENTES CON SÍNDROME DE CUSHING.
Lima-Martínez, M. M., Zerpa, J., Guerrero, Y., Rivera, J., & Vielma, M. (2013)
Effect of obesity on results of dexamethasone suppression test
Pratt, D. W., Warner, J., McLeod, D. S. A., & Donovan, P. J. (2013) · Pathology · doi:10.1097/01.pat.0000426965.73315.7e
The Diagnostic Challenges in ACTH Dependent Cushing’s Disease
Xochitiotzi, E., Martínez, M., Arzola, T., Crespo, R., & Mehta, R. (2015) · International Journal of Medical and Pharmaceutical Case Reports · doi:10.9734/ijmpcr/2015/14571
Diagnosis of adrenocortical cancer
Mel'nichenko, G. A., Stilidi, I. S., Alekseev, B. Y., Beltsevich, D. G., Райхман, А. О., Kuznetsov, N. S., Zhukov, N. V., & Bokhyan, V. Y. (2014) · P A Herzen Journal of Oncology · doi:10.17116/oncolog2014690-94
Zhong, J. L., & Parker, A. C. (2013) · Pathology · doi:10.1097/01.pat.0000426962.06488.2e
The investigation of patients with hypertension: who might have a secondary cause?
Warren, R. E., & Padfield, P. L. (2010) · Clinical Risk · doi:10.1258/cr.2010.010021
Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern
Reincke, M., & Beuschlein, F. (2015)
Ectopic ACTH Syndrome Caused by Multifocal Pulmonary Carsinoids with 18f-FDG Uptake: Case Report
Çakır, İ., Güveli, T. K., Taşdemir, Z. A., Albayrak, R., KAYNAK, K., Batur, Ş., Öz, B., & Karaca, Z. (2016) · Turkiye Klinikleri Journal of Endocrinology · doi:10.5336/endocrin.2016-50345
Zada, G., Lopes, M. B. S., Mukundan, S., & Laws, E. R. (2015) · Springer eBooks · doi:10.1007/978-3-319-22855-6_13
Yedinak, C. G., Brzana, J. A., McCartney, S., & Fleseriu, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_3
Beltsevich, D. G., Russian Federation, & Russian, B. (2014) · Endocrine Surgery
Management Scheme for Adrenal Incidentalomas: Who Gets What?
Callender, G. G., & Udelsman, R. (2016) · Current Surgery Reports · doi:10.1007/s40137-016-0145-2
The Musical Footprint of Cushing Syndrome
Terrier, L., Amelot, A., Velut, S., François, P., & Zemmoura, I. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.2078
Alerraqi, E. (2016) · Hormonal Studies · doi:10.7243/2052-8000-4-1
“Also, El Hadidi has turned a deaf ear to the Guidelines of the Endocrine Society’s Clinical Practice in diagnosing Cushing’s disease [12].”
BackgroundPituitary Adenomas: Evaluation and Management
POPOVIC, V. M. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch32
Encefalopatie metaboliche e tossiche non farmacologiche
Codron, P., & Verny, C. (2016) · EMC - Neurologia · doi:10.1016/s1634-7072(16)78793-9
An 18-Month-Old Boy with Decreasing Height Velocity
Soylu, L., & Chawla, V. (2015) · Pediatric Annals · doi:10.3928/00904481-20151012-04
Katakami, H. (2012) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.101.913
Pituitary disease in pregnancy
Dworakowska, D., & Aylwin, S. J. B. (2012) · CRC Press eBooks · doi:10.1201/b14988-40
Hypercortisolism and Cushing's Syndrome☆
Kyritsi, E. M., Kourkouti, C., Chrousos, G. P., & Charmandari, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99487-x · Cited by 1
Reproductive endocrinology and infertility
OLSEN, M. E., & Rizk, B. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316084380.027
The Challenge of Managing Hypertension in Patients with Diabetes or Other Endocrine Disorders
Rosei, E. A., & Castellano, M. (2011) · US Endocrinology · doi:10.17925/use.2011.07.01.46
“The diagnosis of Cushing’s syndrome relies first on urinary or salivary cortisol measurement and low-dose dexamethasone suppression tests; when unregulated hypercortisolism is demonstrated, plasma ACTH measurement allows differentiation of ACTH-dependent (due to a pituitary or non-pituitary ACTH-secreting tumour) from…”
BackgroundManagement of Adrenal Cortical Tumors
Parikh, M., & Pachter, H. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0823-3.10129-8
Fischer, A. S., Rizk, C. B., & Hsu, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649520.014
Kinderen met obesitas en afbuigende lengtegroeicurve: Ziekte van Cushing?
van Wezel, E. M., van Santen, H. M., van Furth, W. R., Reneman, L., Bisschop, P. H. L. T., & van Trotsenburg, A. S. P. (2013) · Data Archiving and Networked Services (DANS)
Indicaciones e interpretación diagnóstica de las pruebas funcionales hipofisarias
Fernández, C., Troyano, M. J. R., Trifu, D. S., & Montes, P. G. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.06.023
Субклинический гиперкортицизм: необходимость диагностического поиска
Kvacheniuk, A. N., & Луценко, Л. А. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.1.73.2016.71106
Диагностика адренокортикального рака
StiliDi, S., Kuznetsov, S. G., & Sechenov, M. (2014)
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M.
- Affiliations
- National Institutes of Health (US)
- Massachusetts General Hospital (US)
- Medical College of Wisconsin (US)
- University of Sheffield (GB)
- Queen Mary University of London (GB)
- University of Birmingham (GB)
- Mayo Clinic (V.M.M.), Rochester, Minnesota 55905
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-05-01
- Volume
- 93
- Issue
- 5
- Pages
- 1526-1540
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2386281
- OpenAlex
- W1990995386
- Cited by
- 2,718
- References
- 140
- Citations by year
- 2026: 159 · 2025: 173 · 2024: 173 · 2023: 148 · 2022: 212 · 2021: 199 · 2020: 195 · 2019: 165 · 2018: 150 · 2017: 148 · 2016: 158 · 2015: 156 · 2014: 134 · 2013: 139 · 2012: 114
- FWCI
- 70.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- European Society of Endocrinology
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (Z01HD008833)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's syndrome, diagnosis, hypercortisolism, adrenal incidentaloma, dexamethasone suppression test, late-night salivary cortisol, urine cortisol
- MeSH terms
- Cushing Syndrome, Dexamethasone, Humans, Hydrocortisone, Saliva, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.